All Stories

  1. Using single-dose liposomal amphotericin B for cryptococcal meningitis induction therapy: nurse pearls and practical perspectives
  2. A systematic review of fungi isolated from formalin-preserved human and animal cadavers: A potential health concern to exposed students and technicians
  3. Evolution of Laboratory Diagnostics for Cryptococcosis and Missing Links to Optimize Diagnosis and Outcomes in Resource-Constrained Settings
  4. Using single-dose liposomal amphotericin B for cryptococcal meningitis induction therapy: nurse pearls and practical perspectives
  5. Pilot project demonstrating the feasibility of HIV antiretroviral therapy waste bottle collection and recycling
  6. Re-estimation of the burden of serious fungal diseases in Uganda
  7. Fungal diseases in Africa: Closing the gaps in diagnosis and treatment through implementation research and advocacy
  8. Investigating Metabolic and Molecular Ecological Evolution of Opportunistic Pulmonary Fungal Coinfections: Protocol for a Laboratory-Based Cross-Sectional Study
  9. Prevalence of Histoplasma Antigenuria among Outpatient Cohort with Advanced HIV in Kampala, Uganda
  10. Vaginal colonization with virulent Staphylococcus aureus and methicillin resistant Staphylococcus aureus among Ugandan women in labour
  11. Adherence of health workers to guidelines for screening and management of cryptococcal meningitis in Uganda
  12. Diagnostic options for pulmonary fungal diseases in Africa
  13. Building clinical pharmacology laboratory capacity in low- and middle-income countries: Experience from Uganda
  14. Improving mycetoma case detection through the training of community health workers in Northern Uganda: protocol for a stepped-wedge cluster-randomized trial
  15. Invasive Fungal Diseases in Africa: A Critical Literature Review
  16. Aspergillus-specific IgM/IgG antibody serostatus of patients hospitalized with moderate-critical COVID-19 in Uganda
  17. Medical Mycology dissertation topics require prioritisation among Postgraduate Microbiology trainees of Makerere University, Uganda
  18. Chronic pulmonary aspergillosis in patients with active pulmonary tuberculosis with persisting symptoms in Uganda
  19. Evaluation of the initial 12 months of a routine cryptococcal antigen screening program in reduction of HIV-associated cryptococcal meningitis in Uganda
  20. Rates of refusal of clinical autopsies among HIV-positive decedents and an overview of autopsies in Uganda
  21. Rates of refusal of clinical autopsies among HIV-positive decedents and an overview of autopsies in Uganda
  22. Mapping of Chronic Pulmonary Aspergillosis in Africa
  23. Evaluation of the BioFire® FilmArray® Meningitis/Encephalitis panel in an adult and pediatric Ugandan population
  24. Symptomatic Cryptococcal Meningitis with Negative Serum and Cerebrospinal Fluid Cryptococcal Antigen Tests
  25. Surgical management of chronic pulmonary aspergillosis in Africa: A systematic review of 891 cases
  26. Evaluation of the Initial 12 Months of a Routine Cryptococcal Antigen Screening Program in Reduction of HIV-Associated Cryptococcal Meningitis in Uganda
  27. Evaluation of the Diagnostic Performance of a Semiquantitative Cryptococcal Antigen Point-of-Care Assay among HIV-Infected Persons with Cryptococcal Meningitis
  28. Evaluation of an Aspergillus IgG/IgM lateral flow assay for serodiagnosis of fungal asthma in Uganda
  29. A portable magnetofluidic platform for detecting sexually transmitted infections and antimicrobial susceptibility
  30. Fungal asthma among Ugandan adult asthmatics
  31. Misdiagnosis of chronic pulmonary aspergillosis as pulmonary tuberculosis at a tertiary care center in Uganda: a case series
  32. COVID-19 and the HIV care continuum in Uganda: minimising collateral damage
  33. Medical Mycology dissertation topics require prioritisation among Postgraduate Microbiology trainees of Makerere University, Uganda.
  34. Translational research in Uganda: linking basic science to bedside medicine in a resource limited setting
  35. Histoplasmosis overlapping with HIV and tuberculosis in sub-Saharan Africa: challenges and research priorities
  36. Prevalence of Aspergillus fumigatus skin positivity in adults without an apparent/known atopic disease in Uganda
  37. Estimation of the burden of tinea capitis among children in Africa
  38. Evaluation of the Dynamiker Cryptococcal Antigen Lateral Flow Assay for the Diagnosis of HIV-Associated Cryptococcosis
  39. Deep fungal infections diagnosed by histology in Uganda: A 70-year retrospective study
  40. Impact of community engagement and social support on the outcomes of HIV-related meningitis clinical trials in a resource-limited setting
  41. COVID-19 and the HIV care continuum in Uganda: minimising collateral damage
  42. Chronic Pulmonary Aspergillosis: Notes for a Clinician in a Resource-Limited Setting Where There Is No Mycologist
  43. Intra-cavitary pulmonary cryptococcoma in poorly controlled diabetes mellitus
  44. Skin prick reactivity among asthmatics in East Africa
  45. Erratum to “Online Learning Resources Enhanced Teaching and Learning of Medical Mycology among Medical Students in Gulu University, Uganda”
  46. Mycetoma in Uganda: A neglected tropical disease
  47. Deep fungal infections diagnosed by histology in Uganda: a 70-year retrospective study
  48. Tuberculosis in HIV-Associated Cryptococcal Meningitis is Associated with an Increased Risk of Death
  49. Xpert MTB/RIF Ultra for the diagnosis of HIV-associated tuberculous meningitis: a prospective validation study
  50. Online Learning Resources Enhanced Teaching and Learning of Medical Mycology among Medical Students in Gulu University, Uganda
  51. Algorithm-aided diagnosis of chronic pulmonary aspergillosis in low- and middle-income countries by use of a lateral flow device
  52. Performance of Lipoarabinomannan Assay using Cerebrospinal fluid for the diagnosis of Tuberculous meningitis among HIV patients
  53. Getting Histoplasmosis on the Map of International Recommendations for Patients with Advanced HIV Disease
  54. Cor pulmonale complicating chronic pulmonary aspergillosis with fatal consequences: Experience from Uganda
  55. Performance of Lipoarabinomannan Assay using Cerebrospinal fluid for the diagnosis of Tuberculous meningitis among HIV patients
  56. Minimum Inhibitory Concentration Distribution of Fluconazole Against Cryptococcus Species and the Fluconazole Exposure Prediction Model
  57. Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trial
  58. Management of amphotericin-induced phlebitis among HIV patients with cryptococcal meningitis in a resource-limited setting: a prospective cohort study
  59. Burden of fungal asthma in Africa: A systematic review and meta-analysis
  60. The conundrum of clinical trials and standard of care in sub-Saharan Africa – the research nurse perspective
  61. Symptomatic Cryptococcal Antigenemia Presenting as Early Cryptococcal Meningitis With Negative Cerebral Spinal Fluid Analysis
  62. Elevated Aspergillus-specific antibody levels among HIV infected Ugandans with pulmonary tuberculosis
  63. Evaluation of trypan blue stain in the TC20 automated cell counter as a point-of-care for the enumeration of viable cryptococcal cells in cerebrospinal fluid
  64. Evaluation of trypan blue stain in a haemocytometer for rapid detection of cerebrospinal fluid sterility in HIV patients with cryptococcal meningitis
  65. Acridine orange fluorescent microscopy is more sensitive than India ink light microscopy in the rapid detection of cryptococcosis among CrAg positive HIV patients
  66. Cryptococcal disease and the burden of other fungal diseases in Uganda; Where are the knowledge gaps and how can we fill them?
  67. Evaluation of Fingerstick Cryptococcal Antigen Lateral Flow Assay in HIV-Infected Persons: A Diagnostic Accuracy Study: Figure 1.
  68. Comment on: Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic model
  69. Performance of Cryptococcal Antigen Lateral Flow Assay Using Saliva in Ugandans with CD4 <100
  70. Multisite Validation of Cryptococcal Antigen Lateral Flow Assay and Quantification by Laser Thermal Contrast